| 000 | 01616 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513104910.0 | ||
| 264 | 0 | _c19970129 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0033-3158 | ||
| 024 | 7 |
_a10.1007/BF02245604 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeveney, A M | |
| 245 | 0 | 0 |
_aComparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213. _h[electronic resource] |
| 260 |
_bPsychopharmacology _cMar 1996 |
||
| 300 |
_a40-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 | _aBenzodiazepines |
| 650 | 0 | 4 |
_aChromans _xpharmacology |
| 650 | 0 | 4 |
_aClozapine _xpharmacology |
| 650 | 0 | 4 |
_aDibenzothiazepines _xpharmacology |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 |
_aPhenethylamines _xpharmacology |
| 650 | 0 | 4 |
_aPirenzepine _xanalogs & derivatives |
| 650 | 0 | 4 | _aQuetiapine Fumarate |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Dopamine D1 _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xdrug effects |
| 650 | 0 | 4 | _aStereoisomerism |
| 700 | 1 | _aWaddington, J L | |
| 773 | 0 |
_tPsychopharmacology _gvol. 124 _gno. 1-2 _gp. 40-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02245604 _zAvailable from publisher's website |
| 999 |
_c8928207 _d8928207 |
||